1-3 of 3
Horst-Dieter Hummel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Specific NK Cell Activation to Treat Relapsed/Refractory (r/r) Hodgkin Lymphoma (HL) Patients – Final, Updated Data on Clinical Outcome, Pharmacokinetics and Pharmacodynamics of a Phase 1 Study Investigating AFM13, a Bispecific Anti-CD30/CD16A Tandab

Achim Rothe, MD, Stephanie Sasse, MD, Max S. Topp, MD, Dennis A. Eichenauer, MD, Bastian von Tresckow, MD, Horst-Dieter Hummel, MD, Miroslav Ravic, MD PhD, Jens-Peter Marschner, MD, Andreas Engert, MD
Journal: Blood
Blood (2014) 124 (21): 1753.
https://doi.org/10.1182/blood.V124.21.1753.1753
Published: 2014
Journal Articles

Fully Retargeted, Myeloma-Specific Oncolytic Measles Viruses.

Takafumi Nakamura, PhD, Horst-Dieter Hummel, Mary Harvey, Suzanne Greiner, Max Topp, MD, PhD, Stephen J. Russell, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 3478.
https://doi.org/10.1182/blood.V106.11.3478.3478
Published: 2005
Journal Articles

Fully Retargeted Oncolytic Measles Virus Specific for the WUE-Ag Results in Specific Lysis of Multiple Myeloma Cells.

Horst-Dieter Hummel, Takafumi Nakamura, PhD, Gabriele Kuntz, Hermann Einsele, MD, Steve J. Russell, MD, Max S. Topp, MD
Journal: Blood
Blood (2005) 106 (11): 3053.
https://doi.org/10.1182/blood.V106.11.3053.3053
Published: 2005